Axogen, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Axogen, Inc. now
Current reporting with the operating signal separated from the noise.
Analysts Have Made A Financial Statement On Axogen, Inc.'s (NASDAQ:AXGN) Second-Quarter Report
The story matters when it changes Axogen, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Axogen, Inc. 2Q 2026: Revenue $69.73M, EPS ($0.03) — 10-Q Summary
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Axogen, Inc. (NASDAQ: AXGN) grows revenue 24.7% and retires debt
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Axogen, Inc. Raises Earnings Guidance for the Year 2026
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Axogen, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AXGN) 2026-07-29
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Axogen, Inc. (AXGN) Q2 2026 Earnings Call Transcript
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Earnings Flash (AXGN) Axogen, Inc. Posts Q2 Adjusted EPS $0.12 per Share, vs. FactSet Est of $0.12
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Axogen, Inc. (AXGN) Q2 2026 Earnings
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Axogen, Inc. Reports Second Quarter 2026 Financial Results
The story matters when it changes Axogen, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026
The story matters when it changes Axogen, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
Investors are testing whether Axogen, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
The story matters when it changes Axogen, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest AXGN filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Axogen, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →